Opthea Ltd. | Key People and Executives
Geoffrey Paul Kempler
Non-Executive Chairman
Megan Baldwin
Chief Executive Officer, Executive Director & MD
Michael K. Sistenich
Non-Executive Director
Geoffrey Paul Kempler
Non-Executive Chairman
Megan Baldwin
Chief Executive Officer, Executive Director & MD
Michael Tonroe
Chief Financial Officer & Secretary
Ian Leitch
Director-Clinical Research & Development
Angus Tester
Senior Research Scientist
Michael K. Sistenich
Non-Executive Director
| Address |
650 Chapel Street
South Yarra Victoria (VIC) 3141
Australia
|
|
Employees
|
- |
| Website |
http://www.opthea.com |
| Updated |
07/08/2019 |
| Opthea Ltd. is engaged in developing biological therapeutics for cancer and other serious diseases. It is a biologics drug developer building on its significant intellectual property portfolio around Vascular Endothelial Growth Factor C and D angiogenic molecules and R3. The company focuses on vascular endothelial growth factors to develop truly novel therapies to extend and improve the lives of cancer sufferers. |
